DPIIT recognised startup Government of India
Startup India
Stilits Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹83.36 Lakh
▲ 59% YoY
Net profit · FY 2024
₹3.96 Lakh
Net margin 4.8%
EBITDA · FY 2024
₹12.92 Lakh
EBITDA margin 15.5%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Satisfied ₹40 Lakh
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
About Stilits Pharmaceuticals Private Limited
Data last updated:
Stilits Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2017PTC302454. Its GSTIN is 37AAGCD4473K1ZA (Andhra Pradesh).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Naga Venkata Jakka Sita Kusuma Deepthi (Managing Director) and Bharatha Nageswararao.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹83.36 Lakh, a growth of 59% compared to the previous year. For the same year it recorded a net profit of ₹3.96 Lakh (net margin 4.8%) and EBITDA of ₹12.92 Lakh (EBITDA margin 15.5%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 26% over five years.
As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹40 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website daiwapharmaceuticals.com.
Company details
CIN U51909MH2017PTC302454
Registration Number 302454
Incorporation Date 05 December 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Stilits Pharmaceuticals
Contact details
Stilits Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is daiwapharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressHd – 092 Wework Oberoi Commerz II 1st Floor, Cts No. 95 4 B 3 & 4 590 Ff W. E. Highway Oberoi Garden City, Mumbai, Maharashtra, India – 400063
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Stilits Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Stilits Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Stilits Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Stilits Pharmaceuticals Private Limited, buy the company report.
Financials of Stilits Pharmaceuticals Private Limited
FY 2024 filings availableStilits Pharmaceuticals Private Limited reported revenue of ₹83.36 Lakh (up 59% YoY) for FY 2024.
Revenue · FY 2024
₹83.36 Lakh ▲ 59%
Net profit · FY 2024
₹3.96 Lakh margin 4.8%
EBITDA · FY 2024
₹12.92 Lakh margin 15.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 59%
3 years · compounded
▲ 17%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 56%
5 years · compounded
▲ 25%
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 59% growth in the latest year. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.96 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.5% | ||||
| Net Profit Margin | 4.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stilits Pharmaceuticals Private Limited, buy the company report.
Board of directors of Stilits Pharmaceuticals Private Limited
Stilits Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharatha Nageswararao | Director | 22 Feb 2018 | 8 Years 8 Months | Current |
| Naga Venkata Jakka Sita Kusuma Deepthi | Managing Director | 05 Dec 2017 | 8 Years 10 Months | Current |
Peer comparison
Stilits Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lifeway Pharmaceuticals Private Limited | ₹84.16 Lakh (FY 2024) | -42.0% | Hapur, Uttar Pradesh, India | |||
| Stilits Pharmaceuticals Private Limitedthis company | ₹83.36 Lakh (FY 2024) | ₹3.96 Lakh | 4.8% | 59.0% | Mumbai, Maharashtra, India | |
| Zian Pharmaceuticals Private Limited | ₹83.19 Lakh (FY 2022) | 9.0% | Kolkata, West Bengal, India | |||
| Graciella Pharmaceuticals Private Limited | ₹82.45 Lakh (FY 2025) | 46.0% | Nagpur, Maharashtra, India |
To see the full peer comparison of Stilits Pharmaceuticals Private Limited, buy the company report.
Auditor
Stilits Pharmaceuticals Private Limited is audited by T.SREENIVAS & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T.SREENIVAS & CO | FY 2023 | 011575S |
Shareholding
The shareholding of Stilits Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stilits Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹50 Lakh
Satisfied charges
₹40 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Mar 2024 | 100930812 | Others | ₹50 Lakh | Open | |
| 27 May 2021 | 100469709 | Others | ₹20 Lakh | Satisfied | |
| 24 May 2018 | 100187498 | State Bank of India | ₹20 Lakh | Satisfied |
To see the full charge records of Stilits Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Stilits Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stilits Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Stilits Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAGCD4473K1ZA | Andhra Pradesh | Active | 02 Jan 2018 |
To see the full GST registrations and return filing status of Stilits Pharmaceuticals Private Limited, buy the company report.
Recent activity
Stilits Pharmaceuticals Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Narasimha Rani Murthy ceased to be Director on 28 Feb 2018.
AGM
Stilits Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Stilits Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge registered on 27 May 2021 via Charge ID 100469709 with Others was fully satisfied on 07 Mar 2024.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 100930812 was registered on 04 Mar 2024.
Charges
A charge with Others amounted to Rs. 20.00 Lakh with Charge ID 100469709 was registered on 27 May 2021.
Charges
A charge registered on 24 May 2018 via Charge ID 100187498 with State Bank Of India was fully satisfied on 24 Oct 2019.
Charges
A charge with State Bank Of India amounted to Rs. 20.00 Lakh with Charge ID 100187498 was registered on 24 May 2018.
Ceased
Narasimha Rani Murthy ceased to be Director.
Appointed
Bharatha Nageswararao was appointed as Director.
Ceased
Naga Venkata Jakka Sita Kusuma Deepthi ceased to be Director.
Appointed
Naga Venkata Jakka Sita Kusuma Deepthi was appointed as Managing Director.
Incorporation
05 Dec 2017
Stilits Pharmaceuticals Private Limited was registered on 05 Dec 2017 with Roc Mumbai & aged 8 years 10 months as per MCA records.
Frequently asked questions
Stilits Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 December 2017 (9+ years old) and is registered under CIN U51909MH2017PTC302454.
Stilits Pharmaceuticals has 2 current directors:
- Naga Venkata Jakka Sita Kusuma Deepthi - Managing Director
- Bharatha Nageswararao - Director
The latest financial statements of Stilits Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Stilits Pharmaceuticals is 37AAGCD4473K1ZA, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Stilits Pharmaceuticals is U51909MH2017PTC302454. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stilits Pharmaceuticals was incorporated on 05 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Stilits Pharmaceuticals by revenue are Lifeway Pharmaceuticals Private Limited, Zian Pharmaceuticals Private Limited, Graciella Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Narasimha Rani Murthy ceased to be Director on 28 Feb 2018. Bharatha Nageswararao was appointed as Director on 22 Feb 2018. Naga Venkata Jakka Sita Kusuma Deepthi ceased to be Director on 07 Dec 2017. Stilits Pharmaceuticals has 4 board changes on record in total.
Yes, Stilits Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Stilits Pharmaceuticals can be reached through the website daiwapharmaceuticals.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Stilits Pharmaceuticals is at Hd – 092 Wework Oberoi Commerz II 1st Floor, Cts No. 95 4 B 3 & 4 590 Ff W. E. Highway Oberoi Garden City, Mumbai, Maharashtra, India – 400063.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages